Analgesics in Sweden

Date: November 6, 2017
Pages: 20
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A9CE65D3C2CEN
Leaflet:

Download PDF Leaflet

Analgesics displayed modest growth in 2017 as the strong dynamics witnessed in 2016 stabilised from when pharmacies gained share from grocery retailers. The rationale for the dynamics and the following maturity in 2017 was a new regulation on analgesics, introduced in November 2015. The Sweden’s Medical Products Agency (MPA) stated in September 2014 that acetaminophen tablets and capsules sold from retailers, with the exception of chemists/pharmacies and pharmaceutical internet retailers would b...

Euromonitor International's Analgesics in Sweden report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Prospects
Ban on Acetaminophen Pills Results in Strong Dynamics Within Analgesics
Analgesics Value Growth Is Expected To Slow Down Over the Forecast Period
Generics Will Continue To Move Forward
Competitive Landscape
GlaxoSmithKline Consumer Healthcare Continues To Lead Analgesics
Leadership Challenged by Generics
Future for Brand Loyalty
Category Data
  Table 1 Sales of Analgesics by Category: Value 2012-2017
  Table 2 Sales of Analgesics by Category: % Value Growth 2012-2017
  Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
  Table 4 NBO Company Shares of Analgesics: % Value 2013-2017
  Table 5 LBN Brand Shares of Analgesics: % Value 2014-2017
  Table 6 Forecast Sales of Analgesics by Category: Value 2017-2022
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022
Executive Summary
Positive Growth With Continued Importance of the Health and Wellness Trend
Pressurised Retailing Changes and Free Paediatric Prescribed Drugs
Consumer Loyalty in OTC and Curiosity for Newcomers in Other Categories
Unit Prices Pressured Due To Changes in the Retailing Landscape
Behind-the-counter Sales May Become A Reality Over the Forecast Period
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  Table 9 Life Expectancy at Birth 2012-2017
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2012-2017
  Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
  Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
  Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
  Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
  Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
  Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
  Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
  Summary 1 OTC: Switches 2016-2017
Sources
  Summary 2 Research Sources
Skip to top


OTC Pharmaceuticals in Sweden US$ 350.00 Sep, 2014 · 39 pages
Adult Mouth Care in Sweden US$ 990.00 Oct, 2016 · 19 pages
Calming and Sleeping in Sweden US$ 990.00 Apr, 2015 · 21 pages
Digestive Remedies in Sweden US$ 990.00 Nov, 2017 · 20 pages

Ask Your Question

Analgesics in Sweden
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: